Skip to main content
. Author manuscript; available in PMC: 2007 Oct 17.
Published in final edited form as: Toxicol Appl Pharmacol. 2006 Jan 27;214(1):69–77. doi: 10.1016/j.taap.2005.12.006

Fig. 2.

Fig. 2.

Number of anti‐HKSP antibody secreting splenocytes in 3‐month‐old offspring treated prenatally/lactationally with atrazine (solid bars) or placebo (open bars). The spleens of animals were removed 14 days after immunization and the number of HKSP‐specific B cells quantified by the ELISpot assay. The data are presented as the number of antibody secreting cells (spots) normalized to 106 B220+ cells (A; enumerated by flow cytometry) and the number of antibody secreting cells normalized to 106 splenocytes (B) for each sex. Error bars represent the SEM; *indicates that the values obtained for atrazine offspring were significantly (P < 0.05) different from those obtained for control offspring. The data are representative from 1 of 2 experiments (male treated, n = 14 representing offspring from 13 different dams; male controls, n = 16 representing offspring from 12 different dams; female treated, n = 14 from 12 different dams; female controls n = 15 from 14 different dams).